PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Uncovering a healthier remedy for chronic pain

2013-07-18
(Press-News.org) DURHAM, N.C. -- Physicians and patients who are wary of addiction to pain medication and opioids may soon have a healthier and more natural alternative.

A Duke University study revealed that a derivative of DHA (docosahexaenoic acid), a main ingredient of over-the-counter fish oil supplements, can sooth and prevent neuropathic pain caused by injuries to the sensory system. The results appear online in the Annals of Neurology.

The research focused on a compound called neuroprotectin D1=protectin D1 (NPD1=PD1), a bioactive lipid produced by cells in response to external stimuli. NPD1=PD1 is present in human white blood cells, and was first identified based on its ability to resolve abdominal and brain inflammation.

"These compounds are derived from omega-3 fatty acids found in fish oil, but are 1,000 times more potent than their precursors in reducing inflammation," said Ru-Rong Ji, professor of anesthesiology and neurobiology at Duke University Medical Center and principal investigator of the study.

The team used laboratory mouse models of nerve injuries to simulate pain symptoms commonly associated with post-surgical nerve trauma. They treated these animals with chemically-synthesized NPD1=PD1, either through local administration or injection, to investigate whether the lipid compound could relieve these symptoms.

Their findings revealed that NPD1=PD1 not only alleviated the pain, but also reduced nerve swelling following the injuries. Its analgesic effect stems from the compound's ability to inhibit the production of cytokines and chemokines, which are small signaling molecules that attract inflammatory macrophages to the nerve cells. By preventing cytokine and chemokine production, the compound protected nerve cells from further damage. NPD1=PD1 also reduced neuron firing so the injured animals felt less pain.

Ji believes that the new discovery has clinical potential. "Chronic pain resulting from major medical procedures such as amputation, chest and breast surgery is a serious problem," he said. Current treatment options for neuropathic pain include gabapentin and various opioids, which may lead to addiction and destruction of the sensory nerves.

On the other hand, NPD1=PD1 can relieve neuropathic pain at very low doses and, more importantly, mice receiving the treatment did not show signs of physical dependence or enhanced tolerance toward the lipid compound.

"We hope to test this compound in clinical trials," Ji said. The initial stages of the trial could involve DHA administration through diet and injection. "DHA is very inexpensive, and can be converted to NPD1 by an aspirin-triggered pathway," he said. The ultimate goal is to develop a safer approach to managing chronic pain.



INFORMATION:

The research was supported by National Institutes of Health grants R01DE17794; R01DE22743; P01GM095467; R21NS082985; Transformative R01NS67686.

CITATION: "Neuroprotectin/Protectin D1 protects neuropathic pain in mice after nerve trauma," Zhen-Zhong Xu, Xing-Jun Liu, Temugin Berta, Chul-Kyu Park, Ning Lü, Charles N. Serhan and Ru-Rong Ji. Annals of Neurology, online May 18, 2013. DOI: 10.1002/ana.23928



ELSE PRESS RELEASES FROM THIS DATE:

Unattractive people more likely to be bullied at work, new Notre Dame study shows

2013-07-18
It's common knowledge that high school can be a cruel environment where attractive students are considered "popular," and unattractive kids often get bullied. And, while that type of petty behavior is expected to vanish with adulthood, new research proves it does not. Colleagues can be just as immature as classmates. The study by Timothy Judge, professor of management at the University of Notre Dame's Mendoza College of Business, and Brent Scott from Michigan State University, is the first to link attractiveness to cruelty in the workplace. In "Beauty, Personality, ...

Poor sleep in pregnancy can disrupt the immune system and cause birth-related complications

2013-07-18
PITTSBURGH, July 17, 2013 – Poor sleep quality and quantity during pregnancy can disrupt normal immune processes and lead to lower birth weights and other complications, finds a University of Pittsburgh School of Medicine study published today in the journal Psychosomatic Medicine. Women with depression also are more likely than non-depressed women to suffer from disturbed sleep and to experience immune system disruption and adverse pregnancy outcomes. "Our results highlight the importance of identifying sleep problems in early pregnancy, especially in women experiencing ...

Probiotic bacterium lessens severity of Salmonella infections by hoarding iron

2013-07-18
Irvine, Calif., July 17, 2013 — UC Irvine microbiologists have learned how a probiotic bacterium used to treat irritable bowel syndrome can soothe gut bacterial infections caused by Salmonella, paving the way for potential relief from foodborne illnesses that affect millions of people annually. Manuela Raffatellu, assistant professor of microbiology & molecular genetics, and colleagues at UC Irvine and the University of Washington identified how a probiotic strain of E. coli reduces Salmonella colonization by competing with this pathogen for iron, an essential nutrient ...

Discovery of stone monument at El Perú-Waka' adds new chapter to ancient Maya history

2013-07-18
Archaeologists tunneling beneath the main temple of the ancient Maya city of El Perú-Waka' in northern Guatemala have discovered an intricately carved stone monument with hieroglyphic text detailing the exploits of a little-known sixth-century princess whose progeny prevailed in a bloody, back-and-forth struggle between two of the civilization's most powerful royal dynasties, Guatemalan cultural officials announced July 16. "Great rulers took pleasure in describing adversity as a prelude to ultimate success," said research director David Freidel, PhD, a professor of anthropology ...

NASA engineer achieves another milestone in emerging nanotechnology

2013-07-18
A NASA engineer has achieved yet another milestone in his quest to advance an emerging super-black nanotechnology that promises to make spacecraft instruments more sensitive without enlarging their size. A team led by John Hagopian, an optics engineer at NASA's Goddard Space Flight Center in Greenbelt, Md., has demonstrated that it can grow a uniform layer of carbon nanotubes through the use of another emerging technology called atomic layer deposition or ALD. The marriage of the two technologies now means that NASA can grow nanotubes on three-dimensional components, ...

Spectrum Health study first to identify heart attack-causing plaque in living patients

2013-07-18
GRAND RAPIDS, Mich., July 17, 2013 – We may be closer to predicting who is at risk for a heart attack, according to a recently published Spectrum Health study. Researchers with Spectrum Health's Frederik Meijer Heart & Vascular Institute used new imaging technology on patients being treated for heart attacks. The imaging technology allowed researchers to identify the characteristic makeup, or signature, of arterial plaque blocking an artery and causing a heart attack. Knowing what type of plaque is present in narrowed arteries may help a physician determine a patient's ...

TGen-TD2-Scottsdale Healthcare breast cancer pilot study shows value of proteomic mapping

2013-07-18
SCOTTSDALE, Ariz. — July 17, 2013 — The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute (TGen), Translational Drug Development (TD2) and Scottsdale Healthcare, has shown that cancer patients do better when their treatment is guided by molecular profiling. Specifically, 52 percent of patients with advanced breast cancer received clinical benefit — meaning their disease was controlled for a longer time — when their cancer was treated based on addressing the abnormal proteins in their tumor, according to the study conducted ...

Compounds outsmart solid tumors' malfunctioning machinery

2013-07-18
SAN ANTONIO (July 17, 2013) — Molecular biologists in the School of Medicine at The University of Texas Health Science Center San Antonio have found a novel way to fine-tune the activity of cells' protein-disposing machinery, with potentially cancer-fighting effects. This machinery, the proteasome, is deregulated in cancer. Agents called protease inhibitors are viewed as potential anti-cancer therapies, but they indiscriminately curb proteasome activity, which also includes protein recycling. Such strategy is effective to kill cells in aggressive blood cancers but leads ...

Antiepileptic drug use while pregnant impacts early child development

2013-07-18
Children whose mothers took antiepileptic drugs (AEDs) while pregnant are at increased risk of early development issues, according to a new study published in Epilepsia, a journal published by Wiley on behalf of the International League Against Epilepsy (ILAE). Results of the study suggest that children exposed to AEDs in the womb were at risk for difficulties with motor development, language skills, social skills, and autistic traits compared to children whose mothers did not take anti-seizure medications. Medical evidence suggests that epilepsy is fairly common in ...

Ovarian cancer metastases influenced by factors in target tissues

2013-07-18
Philadelphia, PA, July 18, 2013 – Cancer researchers have wondered why ovarian cancer cells are so attracted to the abdominal cavity, especially the omentum, with the hope that such an understanding could lead to better disease management or even prevention. Results from a series of experiments suggest a two-step model of omental colonization in which i) cancer cells are attracted to and lodge within immune cell-containing structures known as milky spots, and ii) fat storage cells (adipocytes) fuel cancer cell growth and spread. This study is scheduled for publication ...

LAST 30 PRESS RELEASES:

Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape

Metformin changes blood metal levels in humans

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

[Press-News.org] Uncovering a healthier remedy for chronic pain